Ahmed Kamal

23PUBLICATIONS
23CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsNeural engineeringBiomolecular modelling and designMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 26, 2026
Design and Synthesis of Combretastatin A4-Chalcone Hybrids as Tubulin Polymerization Inhibitors.

|Jul 12, 2026
Ferroptosis-associated immune modulation enhances temozolomide efficacy in experimental glioblastoma: potential implications for T-cell infiltration and tumour microenvironment dynamics.

|May 27, 2026
(E)-4-(4-Acrylamidophenoxy)-N-Methylpicolinamides as b-Raf/VEGFR-2 Inhibitors with Antiangiogenic Activity in HUVEC and Zebrafish Model.

|May 26, 2026
The design and discovery of topoisomerase-II inhibitors as new cancer drugs: current strategies and future perspectives.

|Mar 04, 2026
Tubulin polymerization inhibitors in early clinical studies as cancer therapeutics.

Ahmed Kamal, Rahaman Shaik, Prasanna Anjaneyulu Yakkalaa

|Jan 26, 2026
Ferroptosis-induced immune modulation: a new frontier in glioblastoma therapy.

Shaik Rahaman, Divya Vohora, Ahmed Kamal

Pageof 4

Frequent Collaborators

5 joint publications

Prasanna Anjaneyulu Yakkala

4 joint publications

Velma Ganga Reddy

2 joint publications

Magdalena Plebanski

2 joint publications

Syed Shafi